Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Poster Presentations

Endocrine tumours and neoplasia

Previous section
Endocrine Disruptors
Table of contents
Next section
Female Reproduction

ea0029p773 | Endocrine tumours and neoplasia

New insights into the molecular and cellular pathogenesis of human craniopharyngioma: do pituitary stem cells underlie the origin of these tumours?

ea0029p774 | Endocrine tumours and neoplasia

Diagnostic and Prognostic Role of 68GA-Dotatate in Patients with Neuroendocrine Tumors

ea0029p775 | Endocrine tumours and neoplasia

Meta-analysis of mRNA, microRNA expression and chromosome aberrations in phaeochromocytoma and neuroblastoma

ea0029p776 | Endocrine tumours and neoplasia

Metformin inhibits the androgen mediated up-regulation of Insulin Growth Factor-I Receptor in prostate cancer cells

ea0029p777 | Endocrine tumours and neoplasia

Investigations into the epigenetic mechanisms regulating the prostanoid receptor EP2 in estrogen dependent breast cancer

ea0029p778 | Endocrine tumours and neoplasia

GPR30, the non classical membrane G protein related estrogen receptor (GPER), is overexpressed in human seminoma and promotes seminoma cell proliferation.

ea0029p779 | Endocrine tumours and neoplasia

Sorafenib stops disease progression in the majority of patients with advanced differentiated thyroid cancer refractory to radioactive iodine.

ea0029p780 | Endocrine tumours and neoplasia

The pilot study on clinical presentation of pituitary adenomas (Pa) in patients with multiple endocrine neoplasia type 1 (Men1) phenotype with and without Men1 mutation

ea0029p781 | Endocrine tumours and neoplasia

Hepatocellular carcinoma (HCC) as a neuroendocrine tumor: a preliminar molecular study.

ea0029p782 | Endocrine tumours and neoplasia

Urinary steroid profiling demonstrates induction of CYP3A4 and inhibition of 5alpha-reductase by mitotane treatment for adrenocortical carcinoma

ea0029p783 | Endocrine tumours and neoplasia

Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels

ea0029p784 | Endocrine tumours and neoplasia

TNFα induced aromatase expression is mediated by the Early Growth Response transcription factors in breast adipose

ea0029p785 | Endocrine tumours and neoplasia

Mitochondrial respiratory chain defects: a novel molecular mechanism of Mitotane for treatment of Adrenocortical Carcinoma

ea0029p786 | Endocrine tumours and neoplasia

Screening of AIP mutations in young Romanian patients with sporadic pituitary adenomas

ea0029p787 | Endocrine tumours and neoplasia

Expression of a novel isoform of thyroid peroxidase (TPO) gene in breast cancer (BC)

ea0029p788 | Endocrine tumours and neoplasia

Is combined radionuclide therapy with 90y-Dotatate and 177lu-Dotatate an effective treatment option for patients with metastasised neuroendocrine tumours? An ongoing study

ea0029p789 | Endocrine tumours and neoplasia

The pathogenesis of non functioning pituitary adenoma with positive staining for glycoproteins is associated with MEG3/DLK1 underexpression/GSTP1 overexpression and modulated by microRNAs (miRNAs)

ea0029p790 | Endocrine tumours and neoplasia

The influence of surgery in the management of recurrent adrenocortical carcinoma.

ea0029p791 | Endocrine tumours and neoplasia

Over-expression of AIP protein in GH3 cells reduces cAMP signalling and Growth hormone secretion

ea0029p792 | Endocrine tumours and neoplasia

Novel 45A>G & 46D>G mutation of SDHB Exon-1 in a Patient with Urinary Bladder & Posterior Mediastinum Paraganglioma.

ea0029p793 | Endocrine tumours and neoplasia

Refractory Seizures as a Presenting Feature of Insulinoma

ea0029p794 | Endocrine tumours and neoplasia

Rare Case of Atypical Pituitary Adenoma: Intermediate form of Adenoma between the common Benign Adenoma & exceedingly rare Pituitary Carcinoma

ea0029p795 | Endocrine tumours and neoplasia

A novel mutation of the MEN1 gene in an Italian family with Multiple endocrine Neoplasia type 1

ea0029p796 | Endocrine tumours and neoplasia

Pheochromocytoma releasing ACTH: two in one.

ea0029p797 | Endocrine tumours and neoplasia

Hypergastrinemia in a Patient with Lymphocytic Colitis and Chronic Gastritis

ea0029p798 | Endocrine tumours and neoplasia

Primary hyperparathyroidism due to a parathyroid adenoma, a parathyroid carcinoma and a subsequent adenoma: A case report

ea0029p799 | Endocrine tumours and neoplasia

Neuroendocrine Tumor with Clinical Characteristics of Insulinoma

ea0029p800 | Endocrine tumours and neoplasia

Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth

ea0029p801 | Endocrine tumours and neoplasia

mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures

ea0029p802 | Endocrine tumours and neoplasia

Disturbed alternative splicing of growth hormone is associated with increased expression of SF2/ASF oncogene in pituitary adenoma

ea0029p803 | Endocrine tumours and neoplasia

Estradiol Potentiates the Inhibitory Effects of SOM230 on Prostate Cells in vitro Up-regulating Ligand Binding Domain Expression of SSTR2 and 5

ea0029p804 | Endocrine tumours and neoplasia

β-Catenin signaling controls tumorigenesis in menin-deficient insulinoma

ea0029p805 | Endocrine tumours and neoplasia

Hypermethylated in cancer 1 (HIC1), a tumour suppressor gene epigenetically deregulated in hyperparathyroid tumours by histone modification

ea0029p806 | Endocrine tumours and neoplasia

Stem cell genes are deregulated in parathyroid tumours

ea0029p807 | Endocrine tumours and neoplasia

Long-acting somatostatin analogues are highly effective in men1 patients with early stage duodeno-pancreatic neuroendocrine tumors

ea0029p808 | Endocrine tumours and neoplasia

Insulin, IGF-II and a low-affinity insulin analog differentially regulate insulin receptor isoform A trafficking and induce a different balance of metabolic and mitogenic effects

ea0029p809 | Endocrine tumours and neoplasia

Immunohistochemical, ChIP, and microarray analysis reveals how stromal AR controls prostate cancer outcome through fibroblast specific action of androgen signalling on ECM production and DNA licensing

ea0029p810 | Endocrine tumours and neoplasia

Looking for the molecular bridge between sex hormone-binding globulin (SHBG) and breast cancer cells

ea0029p811 | Endocrine tumours and neoplasia

Parathyroid atypical adenomas: mutational screening of CDC73/HRPT2 gene

ea0029p812 | Endocrine tumours and neoplasia

Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?

ea0029p813 | Endocrine tumours and neoplasia

Clinical and biochemical characteristics of succinate dehydrogenase (SDH) mutation carriers

ea0029p814 | Endocrine tumours and neoplasia

Efficacy of Everolimus to prevent hypoglycemia in patients with metastatic insulinomas: for the French group of endocrine tumors (GTE-Renaten)

ea0029p815 | Endocrine tumours and neoplasia

Differential TNFα -synthesis and signaling in endocrine tumors after treatment with the Tumor-Vascular-Disrupting Agent ASA404 (vadimezan)

ea0029p816 | Endocrine tumours and neoplasia

Anti-proliferative effect of GHRH antagonist JMR-132 on ovarian cancer cell via EGFR-Akt pathway

ea0029p817 | Endocrine tumours and neoplasia

Characterization of circulating tumor cells in prostate cancer patients

ea0029p818 | Endocrine tumours and neoplasia

Mitotane Inhibits Cell Growth Proliferation and Modulates MRP1 Protein Expression In Different Human Cancer Cell Lines

ea0029p819 | Endocrine tumours and neoplasia

Hormone combinations produce unique steroid receptor binding and regulatory profiles in breast cancer cells

ea0029p820 | Endocrine tumours and neoplasia

Medical and Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Well and Moderately Differentiated Neuroendocrine Tumours

ea0029p821 | Endocrine tumours and neoplasia

Expression of ErbB2 in craniopharyngiomas: Possible therapeutic implications

ea0029p822 | Endocrine tumours and neoplasia

Wnt-signalling in human insulinomas

ea0029p823 | Endocrine tumours and neoplasia

How clinical presentation of insulinoma is changing

ea0029p824 | Endocrine tumours and neoplasia

Effects of mitotane on gene expression in the NCI-H295R cell line

ea0029p825 | Endocrine tumours and neoplasia

Ouabain as an antiproliferative agent on adrenocortical cell models and on primary adrenocortical tumor cells

ea0029p826 | Endocrine tumours and neoplasia

Profile of Patients with Pheochromocytoma & Paraganglioma

ea0029p827 | Endocrine tumours and neoplasia

The role of circulating and tumor infiltrating T-cells on clinical outcome in adrenocortical carcinoma

ea0029p828 | Endocrine tumours and neoplasia

Surgical management of primary hyperparathyroidism in a unit where Intra-operative PTH (IOPTH) monitoring is not routinely performed

ea0029p829 | Endocrine tumours and neoplasia

Enhanced antitumor efficacy of fructose conjugated-gefitinib on lung cancer cell lines in vitro and in vivo

ea0029p830 | Endocrine tumours and neoplasia

Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland

ea0029p831 | Endocrine tumours and neoplasia

Non pituitary effects of GnRH analogues in prostate cancer cells: revertion of maligant phenotype and synergism with bicalutamide and radiotherapy

ea0029p832 | Endocrine tumours and neoplasia

Histone deacetylase inhibitor belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth in hormone refractory models

ea0029p833 | Endocrine tumours and neoplasia

Confirmation of pathogenicity of the MEN1 missense mutations by analysis of protein instability and aberrant splicing

ea0029p834 | Endocrine tumours and neoplasia

Expression of MAPK7 and CCNL1 in corticotrophinomas and functional analysis of miR-143 and miR-145 in corticotrophic tumoral lineage AtT20

ea0029p835 | Endocrine tumours and neoplasia

Tc- 99m Sestamibi parathyroid scan in primary hyperparathyroidism and surgical outcomes

ea0029p836 | Endocrine tumours and neoplasia

Vitamin D from genetics to the clinical in prostate cancer

ea0029p837 | Endocrine tumours and neoplasia

Progesterone receptor B induces autophagy antagonizing the phosphatidylinositol-3 kinase PI3K/AKT pathway in breast cancer cell lines

ea0029p838 | Endocrine tumours and neoplasia

Insulinoma in patients with multiple endocrine neoplasia type 1

ea0029p839 | Endocrine tumours and neoplasia

Multiple endocrine neoplasia syndrome type 1 (MEN-1) in Sardinian population: low prevalence of Men-1 mutations and detection of a new inactivating mutation of the CDKI gene p27

ea0029p840 | Endocrine tumours and neoplasia

Atypical paragangliomas responsible for adrenaline-dominant catecholamine secretion due to ectopic expression of phenylethanolamine-N-methyltransferase

ea0029p841 | Endocrine tumours and neoplasia

Evaluation of patients with adrenal diseases operated laparoscopically between 1997 and 2011

ea0029p842 | Endocrine tumours and neoplasia

Immunohistochemical detection of FSH receptors in endocrine tumors

ea0029p843 | Endocrine tumours and neoplasia

Tumour-asssociated myofibroblasts in parathyroid tumours

ea0029p844 | Endocrine tumours and neoplasia

Establishment of a Multidisciplinary Tumor Board for Patients with Neuroendocrine Neoplasms

ea0029p845 | Endocrine tumours and neoplasia

Low detection Rate of Primary Aldosteronism when Screening Among Hypertensive Patients with Ongoing Medication

ea0029p846 | Endocrine tumours and neoplasia

B-Lymphocyte Stimulator in neuroendocrine tumors: a new prognostic marker?

ea0029p847 | Endocrine tumours and neoplasia

Clinical and morphological characterization of C cell hyperplastic and neoplastic lesions of thyroid

ea0029p848 | Endocrine tumours and neoplasia

Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models

ea0029p849 | Endocrine tumours and neoplasia

Gene expression profile of LNCaP human prostate cancer cells after treatment with an antagonist of growth hormone-releasing hormone

ea0029p850 | Endocrine tumours and neoplasia

Evaluation of beta-cell function and insulin sensitivity in a large series of insulinomas in one single tertiary centre

ea0029p851 | Endocrine tumours and neoplasia

Can proteomic approach help us in diagnosis of Riedel’s thyroiditis? A case report

ea0029p852 | Endocrine tumours and neoplasia

Effect of dopamine agonists on the tumor size of prolactinomas: are suppressive doses different from those that normalize prolactin serum levels?

ea0029p853 | Endocrine tumours and neoplasia

Expressions of estrogen receptor-β splicing variants in papillary thyroid cancer

ea0029p854 | Endocrine tumours and neoplasia

The high-mobility group A1-oestrogen receptor β nuclear interaction impairs in human testicular seminomas

ea0029p855 | Endocrine tumours and neoplasia

Long-term outcome of primary endocrine non-Hodgkin lymphomas

ea0029p856 | Endocrine tumours and neoplasia

Performances of a new automated chromogranin-A assay

ea0029p857 | Endocrine tumours and neoplasia

Virilization due to adrenocortical carcinoma in a 7 years-old female: a case report

ea0029p858 | Endocrine tumours and neoplasia

Diagnosis and treatment of the surgical pathology of the suprarrenales glands. Bibliographical revision

ea0029p859 | Endocrine tumours and neoplasia

1,25-Dihydroxyvitamin D inhibits cell proliferation by promoting cell-cycle arrest in the human adrenocortical cancer cell line nci-h295r

ea0029p860 | Endocrine tumours and neoplasia

A case of multiple endocrine neoplasia type 2a associated with rectal adenocarcinoma

ea0029p861 | Endocrine tumours and neoplasia

Leptin affects gene expression in OVCAR-3 ovarian cancer cells. Effects on cell proliferation and apoptosis

ea0029p862 | Endocrine tumours and neoplasia

Malignant adrenal incidentaloma

ea0029p863 | Endocrine tumours and neoplasia

Maxillary gland could harbor a neuroendocrine metastasis

ea0029p864 | Endocrine tumours and neoplasia

Circadian rhythm of prolactin release in patients with breast cancer

ea0029p865 | Endocrine tumours and neoplasia

Non-medullary neuroendocrine carcinoma in the thyroid gland: a case-report

ea0029p866 | Endocrine tumours and neoplasia

Adrenal myelolipomas in CAH: is there role for ultrasound screening of the adrenal glands?

ea0029p867 | Endocrine tumours and neoplasia

An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family

ea0029p868 | Endocrine tumours and neoplasia

Medullary thyroid carcinoma with liver metastasis presenting as watery diarrhea for 1 year

ea0029p869 | Endocrine tumours and neoplasia

Antiproliferative effect and control of catecholamine release with octreotide in a patient with giant bilateral pheochromocytoma

ea0029p870 | Endocrine tumours and neoplasia

Survival of patients with adrenocortical carcinoma: experience of one center

ea0029p871 | Endocrine tumours and neoplasia

Leydig cell tumor of ovary: a rare case of virilization

ea0029p872 | Endocrine tumours and neoplasia

Lutetium-177 DOTATATE for paraganglioma refractory to conventional chemotherapy: a single case report

ea0029p873 | Endocrine tumours and neoplasia

Hypoglycemia by insulinoma: for the purposes of a case

ea0029p874 | Endocrine tumours and neoplasia

Atypical presentation of type 1 gastric neuroendocrine tumor should increase our awareness

ea0029p875 | Endocrine tumours and neoplasia

A case of multiple endocrine neoplasia type 1 associated with multicentric VIPoma

ea0029p876 | Endocrine tumours and neoplasia

Disseminated insulinoma in 13-year-old patient

ea0029p877 | Endocrine tumours and neoplasia

Management of ectopic Cushing’s syndrome caused by bronchial carcinoid: four case reports

ea0029p878 | Endocrine tumours and neoplasia

Metastatic malignant insulinoma

ea0029p879 | Endocrine tumours and neoplasia

A rare case of hirsutism: mucinous cystoadenoma of the ovary with stromal luteinization and hilar cell hyperplasia

ea0029p880 | Endocrine tumours and neoplasia

Neuroendocrine tumors of the gastrointestinal tract: a descriptive study

ea0029p881 | Endocrine tumours and neoplasia

Prediction of remission of gestational trophoblastic disease based on initial levels of prolactin

ea0029p882 | Endocrine tumours and neoplasia

Radioguided cortical-sparing approach for recurrent pheocromocytoma/paragangliomas

ea0029p883 | Endocrine tumours and neoplasia

Clinically palpable parathyroid adenoma

ea0029p884 | Endocrine tumours and neoplasia

Special diagnostic, therapeutic and evolutive aspects of insulinoma: a tunisian experience

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more